Solving the conundrum of insoluble protein aggregates

[1]  M. Diamond,et al.  The prion model for progression and diversity of neurodegenerative diseases , 2017, The Lancet Neurology.

[2]  J. Ule,et al.  Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging , 2017, Cell reports.

[3]  Rob Knight,et al.  Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease , 2016, Cell.

[4]  M. Diamond,et al.  Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo , 2016, Neuron.

[5]  L. Fidani,et al.  The genetic background of Parkinson's disease: current progress and future prospects , 2016, Acta neurologica Scandinavica.

[6]  Jiancheng Liu,et al.  Tet3 Reads 5-Carboxylcytosine through Its CXXC Domain and Is a Potential Guardian against Neurodegeneration. , 2016, Cell reports.

[7]  A. Ludolph,et al.  Age-dependent defects of alpha-synuclein oligomer uptake in microglia and monocytes , 2016, Acta Neuropathologica.

[8]  M. Chin-Chan,et al.  Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases , 2015, Front. Cell. Neurosci..

[9]  Yong Tae Kwon,et al.  Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies , 2015, Experimental & Molecular Medicine.

[10]  Susan Lindquist,et al.  Mechanisms of protein-folding diseases at a glance , 2014, Disease Models & Mechanisms.

[11]  Markus Tolnay,et al.  The propagation of prion-like protein inclusions in neurodegenerative diseases , 2010, Trends in Neurosciences.